Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / WST - West Pharmaceutical Services: Still Too Expensive After The Recent Drop


WST - West Pharmaceutical Services: Still Too Expensive After The Recent Drop

2024-02-19 22:16:57 ET

Summary

  • West Pharmaceutical Services has shown strong financial performance, with a total return of 652.5% in the last 10 years.
  • In its most recent Q4 2023 results, the company put up relatively flat growth, and a continuation of the trend is expected in 2024.
  • While the company benefits long-term from secular tailwinds, the valuation is far too expensive for a single-digit growth company, especially after a 51% rise in the share price in 2023.

Introduction

For further details see:

West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Stock Information

Company Name: West Pharmaceutical Services Inc.
Stock Symbol: WST
Market: NYSE
Website: westpharma.com

Menu

WST WST Quote WST Short WST News WST Articles WST Message Board
Get WST Alerts

News, Short Squeeze, Breakout and More Instantly...